期刊文献+

甲状腺髓样癌35例治疗体会 被引量:1

Experience in Treatment of 35 Cases Medullary Thyroid Carcinoma
下载PDF
导出
摘要 目的总结甲状腺髓样癌(medullary thyroid carcinoma,MTC)临床特征及治疗方法。方法回顾分析1997年1月~2005年12月经治的35例MTC的临床及病理资料。结果35例均予手术切除原发灶并加行颈淋巴结清扫术,术后放疗5例,化疗7例。所有病例均经病理证实为MTC,淋巴结转移率为51.4%。32例术后随访2~10年,5年生存率为87.5%。结论MTC治疗应以根治性切除为原则,切除范围应比其他类型的甲状腺癌积极,术后可以辅以多种非手术治疗。 Objective To discuss the clinical characteristics and treatment of medullary thyroid carcinoma (MTC). Method The clinical and pathological data of 35 cases of MTC was retrospectively analyzed. Results Total thyroideetomy and cervical lymph node dissection were performed in all the 35 cases. Radiotherapy in 5 cases and chemotherapy in 7 cases were adopted 'after operation. The lymph node metastasis rate was 51.4%. In 32 cases who were followed up for 2 to 10 years, the 5-year survival rate was 87.5%. Conclusion Surgery is considered as the only satisfactory treatment for MTC. Dissection area should be more radical compared with other thyroid carcinoma. Nonsurgical therapies, such as radiotherapy and chemotherapy, would be adopted after the operation.
出处 《中国现代手术学杂志》 2007年第6期438-440,共3页 Chinese Journal of Modern Operative Surgery
关键词 甲状腺肿瘤 thyroid neoplasms
  • 相关文献

参考文献12

  • 1Cohen MS, Moley JF. Surgical treatment of medullary thyroid carcinoma[J]. J lntem Med, 2003, 253 (6) :616-626.
  • 2Giuffrida D, Gharib H. Current diagnosis and management of medullary thyroid carcinoma[J]. Ann Oncol, 1998, 9(7):695-701.
  • 3Orlandi F, Caraci P, Mussa A, et al. Treatment of medullary thyroid carcinoma: an update [ J ]. Endocr Relat Cancer, 2001, 8 (2) :135-147.
  • 4Dixon E, McKinnon JG, Pasieka JL. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms [ J]. World J Surg, 2000, 24( 11 ) : 1396-1401.
  • 5Yen TW, Shapiro SE, Gagel RF, et al. Medullary thyroid carcinoma : results of a standardized surgical approach in a contemporary series of 80 consecutive patients[J]. Surgery, 2003, 134(6) : 890-899.
  • 6Chiu AC, Delpassand ES, Sherman SI. Prognosis and treatment of brain metastases in thyroid carcinoma [ J ]. J Clin Endocrinol Metab, 1997, 82( 11 ) :3637-3642.
  • 7Nocera M, Baudin E, Pellegriti G, et al. Treatment of advanced medullary thyroid cancer with an alternating combination of doxoru-bicin-streptozocin and 5 FU-dacarbazine. Groupe dEtude des Tu- meurs ~ Calcitonine ( GETC ) [ J ]. Br J Cancer, 2000, 83 (6) : 715-718.
  • 8Stein R, Goldenberg DM. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy [ J ]. Mol Cancer Ther, 2004, 3 ( 12 ) : 1559- 1564.
  • 9Modigliani E, Franc B, Niccoli-sire P. Diagnosis and treatment of medullary thyroid cancer[ J]. Baillieres Best Pract Res Clin Endocrinol Metab, 2000, 14(4) :631-649.
  • 10Vainas 1, Koussis Ch, Pazaitou-Panayiotou K, et al. Somatostatin receptor expression in vivo and response to somatostatin analog therapy with or without other antineoplastic treatments in advanced medullary thyroid carcinoma[J]. J Exp Clin Cancer Res, 2004, 23 (4) :549-559.

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部